Cargando…

Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals

Approximately 51 million individuals suffer from lymphatic filariasis (LF) caused mainly by the filarial worm Wuchereria bancrofti. Mass drug administration (MDA) programs led to a significant reduction in the number of infected individuals, but the consequences of the treatment and clearance of inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamadaho, Ruth S. E., Osei-Mensah, Jubin, Arndts, Kathrin, Debrah, Linda Batsa, Debrah, Alexander Y., Layland, Laura E., Hoerauf, Achim, Pfarr, Kenneth, Ritter, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223000/
https://www.ncbi.nlm.nih.gov/pubmed/37242335
http://dx.doi.org/10.3390/pathogens12050665
_version_ 1785049835306483712
author Tamadaho, Ruth S. E.
Osei-Mensah, Jubin
Arndts, Kathrin
Debrah, Linda Batsa
Debrah, Alexander Y.
Layland, Laura E.
Hoerauf, Achim
Pfarr, Kenneth
Ritter, Manuel
author_facet Tamadaho, Ruth S. E.
Osei-Mensah, Jubin
Arndts, Kathrin
Debrah, Linda Batsa
Debrah, Alexander Y.
Layland, Laura E.
Hoerauf, Achim
Pfarr, Kenneth
Ritter, Manuel
author_sort Tamadaho, Ruth S. E.
collection PubMed
description Approximately 51 million individuals suffer from lymphatic filariasis (LF) caused mainly by the filarial worm Wuchereria bancrofti. Mass drug administration (MDA) programs led to a significant reduction in the number of infected individuals, but the consequences of the treatment and clearance of infection in regard to host immunity remain uncertain. Thus, this study investigates the composition of myeloid-derived suppressor cells (MDSCs), macrophage subsets and innate lymphoid cells (ILCs), in patent (circulating filarial antigen (CFA)+ microfilariae (MF)+) and latent (CFA+MF−) W. bancrofti-infected individuals, previously W. bancrofti-infected (PI) individuals cured of the infection due to MDA, uninfected controls (endemic normal (EN)) and individuals who suffer from lymphoedema (LE) from the Western Region of Ghana. Frequencies of ILC2 were significantly reduced in W. bancrofti-infected individuals, while the frequencies of MDSCs, M2 macrophages, ILC1 and ILC3 were comparable between the cohorts. Importantly, clearance of infection due to MDA restored the ILC2 frequencies, suggesting that ILC2 subsets might migrate to the site of infection within the lymphatic tissue. In general, the immune cell composition in individuals who cured the infection were comparable to the uninfected individuals, showing that filarial-driven changes of the immune responses require an active infection and are not maintained upon the clearance of the infection.
format Online
Article
Text
id pubmed-10223000
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102230002023-05-28 Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals Tamadaho, Ruth S. E. Osei-Mensah, Jubin Arndts, Kathrin Debrah, Linda Batsa Debrah, Alexander Y. Layland, Laura E. Hoerauf, Achim Pfarr, Kenneth Ritter, Manuel Pathogens Article Approximately 51 million individuals suffer from lymphatic filariasis (LF) caused mainly by the filarial worm Wuchereria bancrofti. Mass drug administration (MDA) programs led to a significant reduction in the number of infected individuals, but the consequences of the treatment and clearance of infection in regard to host immunity remain uncertain. Thus, this study investigates the composition of myeloid-derived suppressor cells (MDSCs), macrophage subsets and innate lymphoid cells (ILCs), in patent (circulating filarial antigen (CFA)+ microfilariae (MF)+) and latent (CFA+MF−) W. bancrofti-infected individuals, previously W. bancrofti-infected (PI) individuals cured of the infection due to MDA, uninfected controls (endemic normal (EN)) and individuals who suffer from lymphoedema (LE) from the Western Region of Ghana. Frequencies of ILC2 were significantly reduced in W. bancrofti-infected individuals, while the frequencies of MDSCs, M2 macrophages, ILC1 and ILC3 were comparable between the cohorts. Importantly, clearance of infection due to MDA restored the ILC2 frequencies, suggesting that ILC2 subsets might migrate to the site of infection within the lymphatic tissue. In general, the immune cell composition in individuals who cured the infection were comparable to the uninfected individuals, showing that filarial-driven changes of the immune responses require an active infection and are not maintained upon the clearance of the infection. MDPI 2023-04-30 /pmc/articles/PMC10223000/ /pubmed/37242335 http://dx.doi.org/10.3390/pathogens12050665 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tamadaho, Ruth S. E.
Osei-Mensah, Jubin
Arndts, Kathrin
Debrah, Linda Batsa
Debrah, Alexander Y.
Layland, Laura E.
Hoerauf, Achim
Pfarr, Kenneth
Ritter, Manuel
Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title_full Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title_fullStr Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title_full_unstemmed Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title_short Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
title_sort reduced type 2 innate lymphocyte cell frequencies in patent wuchereria bancrofti-infected individuals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223000/
https://www.ncbi.nlm.nih.gov/pubmed/37242335
http://dx.doi.org/10.3390/pathogens12050665
work_keys_str_mv AT tamadahoruthse reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT oseimensahjubin reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT arndtskathrin reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT debrahlindabatsa reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT debrahalexandery reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT laylandlaurae reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT hoeraufachim reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT pfarrkenneth reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals
AT rittermanuel reducedtype2innatelymphocytecellfrequenciesinpatentwuchereriabancroftiinfectedindividuals